Latest Bone density Stories
Patients with celiac disease are more than 4.5 times more likely to develop osteoporosis compared to healthy people in an age and gender matched cohort with no identifiable risk factors for osteoporosis.
ATLANTA, May 24, 2011 /PRNewswire/ -- Carol Donald is a vibrant, active 63-year-old woman who has been living with osteoporosis for over 10 years. With her bone density compromised, Carol suffered from a fracture in her spine when she was involved in a car accident earlier this year.
Women with osteoporosis in their hip suffer menopause two years earlier than healthy women.
PHILADELPHIA, March 24, 2011 /PRNewswire/ -- Tarsa Therapeutics today announced that the Phase III ORACAL trial of its oral recombinant salmon calcitonin in the treatment of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, positive top-line results.
THOUSAND OAKS, Calif., March 23, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced new long-term data showing that during the fourth and fifth years of ProliaÂ® (denosumab) treatment, postmenopausal women with osteoporosis receiving Prolia continued with further, statistically significant, year-over-year increases in lumbar spine and total hip bone mineral density (BMD), a key measurement of bone strength.
THOUSAND OAKS, Calif., March 23, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced new data that showed postmenopausal women with osteoporosis had significantly greater adherence, compliance, and persistence during ProliaÂ® (denosumab) treatment than during alendronate treatment, an oral bisphosphonate commonly used to treat osteoporosis.
The same medicines used to treat angina and chronic heart failure, may also help treat osteoporosis.
Older women who used bisphosphonates (medications that prevent loss of bone mass) for five years or more were more likely to experience "atypical" fractures involving the femoral shaft (bone in the leg that extends from the hip to the knee) or subtrochanteric (fractures in the bone just below the hip joint), compared to women with less usage.
Preliminary research indicates that use of nitroglycerin ointment among postmenopausal women for 2 years was associated with a modest increase in bone mineral density and decrease in bone resorption (loss).
Pediatric Implants designed to help heal broken bones, may actually be damaging the very bones they were intended to treat.
- Growing in low tufty patches.